Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

At the intersection of a red meat allergy and a cancer-drug reaction investigations, researchers pinned a lone star culprit.

Learn about food allergies, food intolerance, types of food allergies, symptoms, and effective food allergy treatments to ...

Researchers at King’s are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...

Researchers at King's are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...

Researchers at King's are the first in the world to develop a treatment from a different type of antibody, called IgE. IgE has important roles in triggering the immune response during an allergic ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, announced that it has completed the acquisition of TigaTx, Inc, a biotechnology company developing ...

Both companies are focused on immunoglobulin antibodies, with Epsilogen’s work orienting around IgE, while TigaTX has been hard at work developing IgA therapies. The deal, for which Epsilogen is ...

an anti-Folate Receptorα IgE antibody, currently in a Phase Ib Proof of Concept trial in platinum-resistant ovarian cancer. Data from a Phase I trial found it to be safe and well tolerated with ...

IgE, which is a specific class of monoclonal antibody, triggers reactions after people are exposed to allergens, Grossman said. “Individuals with AGS have IgE specific to various animal proteins ...

However, this treatment is not always effective in some patients. Now scientists have investigated a different antibody type, IgE, which activates the patient's immune system in different ways to IgG.